MAPT and Alzheimer disease: Tau-PET data from 465 participants from the Alzheimer’s Disease Neuroimaging Initiative (aged 55 to 90) were classified as T+ or T– using decision rules for the Temporal-Occipital Classification (TOC), Simplified TOC (STOC), and Lobar Classification (LC) tau pathologic schemes of Schwarz, and Chen staging scheme.